Machine Learning

Redpoint Advisors' acquisition of VoxCroft Analytics integrates advanced AI to decode complex regions, signaling a new era for technology-driven risk management.

A landmark collaboration between Wolters Kluwer and Spain's General Council of Economists aims to tackle the digital skills gap and redefine the profession.

As AI's energy demand soars, a new generation of cooling technology is crucial. Schneider Electric's latest innovation aims to make AI sustainable.

An innovator in single-molecule imaging is teaming up with a multiplex giant. This collaboration could redefine diagnostic sensitivity and market dynamics.

A Seoul-based AI firm, backed by giants, is set to tackle Southeast Asia's multilingual complexity. This is the story of how AI is becoming the new lingua franca for trade.

A new AI model from ZeroToOne.AI and GroundTruth predicts consumer behavior with startling accuracy, promising to end wasted ad spend and reshape marketing.

With fraud shifting across the customer journey, a new AI platform promises to approve more good customers by analyzing risk from account creation to post-purchase.

As AI-powered crime surges, DataVisor appoints scaling expert Patrick Harr to lead the charge, betting on AI-native defense to win the war on fraud.

Therini Bio's novel drug THN391 enters trials, targeting inflammation in diabetic eye disease, while a next-gen combo therapy aims to redefine care.

With backing from GV and Dexcom, Signos is using AI and OTC glucose monitors to offer a new path for sustainable weight management beyond GLP-1 drugs.

Sensorium Therapeutics advances SNTX-2643, a novel anxiety drug, while adding a new CMO and an expert advisory board to guide its clinical journey.

A new AI-powered screening system at LaGuardia's Terminal B promises frictionless security, but can the tech firm behind it balance growth with finances?

A new partnership between biotech leader Debut and Amazonian expert Natura aims to revolutionize anti-aging skincare with AI-discovered ingredients.

A new survey reveals 4 in 5 tech leaders feel pressured to exaggerate AI success, creating a trillion-dollar paradox of high spending and low returns.

As AI speeds up coding, quality suffers. Checksum's new autonomous agent generates and self-heals tests to close the gap without human intervention.

With a new CCO known for creating unicorns, Ideon Technologies aims to revolutionize mining with subsurface imaging powered by particles from deep space.

The revived MoviePass partners with 5,000 independent theaters, a landmark deal that could save local cinemas and secure the subscription service's future.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

A new partnership between TD2 Oncology and Panome Bio aims to merge clinical expertise with deep multi-omics data to accelerate personalized cancer therapies.

With CHF 105 million in new funding, NUCLIDIUM is advancing its novel copper-based radiotheranostics for metastatic prostate and breast cancer.